Deutsche Bank’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-369
| Closed | -$80K | – | 5000 |
|
|
2021
Q1 | $80K | Sell |
369
-325,938
| -100% | -$61.3M | ﹤0.01% | 4095 |
|
|
2020
Q4 | $37.7M | Buy |
326,307
+18,164
| +6% | +$2.03M | 0.02% | 595 |
|
|
2020
Q3 | $30M | Buy |
308,143
+2
| +0% | +$230 | 0.02% | 586 |
|
|
2020
Q2 | $37.8M | Buy |
308,141
+31,463
| +11% | +$3.57M | 0.03% | 514 |
|
|
2020
Q1 | $24.2M | Sell |
276,678
-25,161
| -8% | -$2.66M | 0.02% | 587 |
|
|
2019
Q4 | $31.6M | Sell |
301,839
-49,776
| -14% | -$5.58M | 0.02% | 617 |
|
|
2019
Q3 | $40.4M | Buy |
351,615
+61,273
| +21% | +$9.3M | 0.03% | 541 |
|
|
2019
Q2 | $50.1M | Buy |
290,342
+35,339
| +14% | +$6.11M | 0.03% | 570 |
|
|
2019
Q1 | $43M | Sell |
255,003
-15,572
| -6% | -$2.32M | 0.03% | 636 |
|
|
2018
Q4 | $26.4M | Buy |
270,575
+37,769
| +16% | +$4.96M | 0.02% | 747 |
|
|
2018
Q3 | $40.2M | Sell |
232,806
-103,055
| -31% | -$14.9M | 0.02% | 744 |
|
|
2018
Q2 | $46.9M | Buy |
335,861
+65,804
| +24% | +$9.35M | 0.02% | 701 |
|
|
2018
Q1 | $30.4M | Buy |
270,057
+41,851
| +18% | +$5.26M | 0.01% | 871 |
|
|
2017
Q4 | $30.1M | Buy |
228,206
+159,783
| +234% | +$18.8M | 0.02% | 759 |
|
|
2017
Q3 | $6.94M | Sell |
68,423
-79,710
| -54% | -$8.54M | ﹤0.01% | 1697 |
|
|
2017
Q2 | $14.8M | Sell |
148,133
-40,696
| -22% | -$4.38M | 0.01% | 1126 |
|
|
2017
Q1 | $22.8M | Buy |
188,829
+12,302
| +7% | +$1.51M | 0.02% | 822 |
|
|
2016
Q4 | $19.7M | Buy |
176,527
+72,333
| +69% | +$8.71M | 0.02% | 867 |
|
|
2016
Q3 | $13.8M | Buy |
104,194
+19,695
| +23% | +$1.88M | 0.01% | 1100 |
|
|
2016
Q2 | $7.74M | Buy |
84,499
+42,135
| +99% | +$3.55M | 0.01% | 1465 |
|
|
2016
Q1 | $3.06M | Sell |
42,364
-36,597
| -46% | -$2.01M | ﹤0.01% | 2077 |
|
|
2015
Q4 | $5.48M | Buy |
78,961
+72,088
| +1,049% | +$5.87M | ﹤0.01% | 1729 |
|
|
2015
Q3 | $627K | Buy |
6,873
+2,069
| +43% | +$230K | ﹤0.01% | 3245 |
|
|
2015
Q2 | $589K | Sell |
4,804
-1,819
| -27% | -$206K | ﹤0.01% | 3300 |
|
|
2015
Q1 | $602K | Buy |
6,623
+3,877
| +141% | +$315K | ﹤0.01% | 3197 |
|
|
2014
Q4 | $185K | Buy |
2,746
+1,746
| +175% | +$128K | ﹤0.01% | 4349 |
|
|
2014
Q3 | $80K | Hold |
1,000
| – | – | ﹤0.01% | 4629 |
|
|
2014
Q2 | $107K | Sell |
1,000
-14,700
| -94% | -$1.02M | ﹤0.01% | 4530 |
|
|
2014
Q1 | $931K | Buy |
+15,700
| New | +$934K | ﹤0.01% | 2911 |
|
Other funds holding GWPH
Deutsche Bank's GWPH Position: Q2 2021 in Review
Deutsche Bank sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 369 shares — an estimated $80K sold.
Deutsche Bank first reported a position in GWPH in Q1 2014 and held it in 29 quarters. The position peaked at $50.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Deutsche Bank reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 369 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $80K.
- Deutsche Bank first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 29 quarters.
- Deutsche Bank's GW Pharmaceuticals Plc American Depositary Shares position peaked at $50.1M in Q2 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.